 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval" E; n Z; Y3 t5 b) _# w0 C
: j$ N+ j5 }% D* D+ N: |" r# D
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.- l0 E0 S% B" j% R* e; R% C, F+ ~
1 f$ Z- I/ `4 Q5 z5 V' T' X, JBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
, ?+ a0 F' z0 n) w0 i- B) d% E2 o 7 d) I, |9 r% R! z. Q9 C. y1 g3 n, b7 D
1 \" X5 N7 u4 j& c* l$ F' lEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
* `$ ]& T5 V- ^5 ?0 C4 R# h9 D& ^) F
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
0 l2 e; a! s3 A$ ]/ N2 I7 _# t" u/ n0 g, C4 l9 W! |
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.. b' ~! a1 w2 `: T; ]1 l+ x
+ X6 F- A S6 sIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
( p6 O4 s4 @" O
& v8 r( [/ Q5 MIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.& k8 h( T& H- O* B* D# n7 l5 b8 s1 E" i
* @2 F& U1 s2 `) L: k"As a scientist, it's one of the highlights of my CAREER," Shan said.
5 } z; O# t) g; @! a- J1 |! n( q! u
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
. F' l& R& W! ]2 z. T) i3 _! ~
. b2 b0 J8 ?) V. V6 AIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.! }' Q& c& f' B* J
- b. U; Y7 h* h6 `Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.& D5 n, w" g/ |9 g3 K
4 S6 u# Q9 C6 v' C. j9 r$ rThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
2 i5 s, k4 P# e: p( M
9 Z) X4 W5 Y- N) _# r! m Q0 d5 B+ {- F( ~$ p
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
' D2 Q- q) O% x1 R7 Y" Z& V4 h
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
